The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Gilead Sciences (I)
Research Funding - Juno Therapeutics
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
 
Perrin Romine
No Relationships to Disclose
 
Jenna M. Voutsinas
No Relationships to Disclose
 
Vicky Wu
No Relationships to Disclose
 
Micah Tratt
No Relationships to Disclose
 
Jay Justin Liao
No Relationships to Disclose
 
Upendra Parvathaneni
No Relationships to Disclose
 
Brittany Barber
No Relationships to Disclose
 
Jasjit Dillon
No Relationships to Disclose
 
Mari-Alina Timoshchuk
No Relationships to Disclose
 
Neal D. Futran
Consulting or Advisory Role - Stryker
 
Jeffrey Houlton
No Relationships to Disclose
 
George E. Laramore
No Relationships to Disclose
 
Renato G. Martins
Honoraria - Roche/Genentech
Research Funding - Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
 
Keith D. Eaton
Research Funding - Mirati Therapeutics (Inst)
 
Cristina P. Rodriguez
Consulting or Advisory Role - AstraZeneca (I); Merck (I)
Speakers' Bureau - CUE Biopharma
Research Funding - AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Ignyta (Inst); Kura Oncology (Inst); Merck (Inst)